45 results
8-K/A
EX-99.2
ELTX
Elicio Therapeutics Inc.
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
Elicio has classified convertible preferred stock, par value $0.001 per share, (the “Preferred Stock”) as temporary equity in the accompanying consolidated … . Leases will be classified as finance or operating, with classification affecting the pattern and classification of expense recognition in the statement
8-K/A
EX-99.1
5xyok4 op
11 Aug 23
Elicio Therapeutics, Inc. Financial Statements
9:13pm
8-K
EX-99.5
999z9cq93
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
8-K
EX-99.4
54m24g1r nmn
2 Jun 23
Angion Biomedia Corp. Announces 1-for-10 Reverse Stock Split
4:36pm
424B3
ndo5 wzh9tru
28 Apr 23
Prospectus supplement
4:07pm
S-4/A
wvgz1ke96xtlzor
29 Mar 23
Registration of securities issued in business combination transactions (amended)
5:29pm
424B5
6kj92
24 May 22
Prospectus supplement for primary offering
4:02pm
424B3
ze2kokylcs4yuhrs1ppd
24 May 22
Prospectus supplement
4:01pm
S-3
ars0j1e
16 May 22
Shelf registration
5:23pm